ACOG Alpha Cognition Inc

P/E --
Forward P/E 26.88
Price/Sales 13.89
Beta 2.232
Div Yield --
Market Cap --

Company Analysis

Latest News

🟒 Alpha Cognition is trading 6.4% up in after-hours trading without a confirmed catalyst

Alpha Cognition is trading 6.4% up now at $9.75 after closing at $9.16 on August 28, 2026; no confirmed company-specific after-hours announcement, earnings...

πŸ”΄ Alpha Cognition falls 5.4% β€” Biotech Sector Declines Amid Fed Rate Hike Fears

With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...

πŸ”΄ Alpha Cognition is trading 12.69% down in pre-market β€” catalyst remains uncertain

Alpha Cognition is trading 12.69% down at $8.50 after closing at $9.73 on August 27, with no fresh company-specific announcement or earnings release explaining...

🟒 Alpha Cognition is trading 6% up today amid broader risk-on sentiment

Alpha Cognition is trading 6% up now at $9.97 on August 27, 2026, with no new company-specific catalyst identified and the move appearing consistent with...

πŸ”΄ Alpha Cognition is trading 5% down today with no clear company-specific catalyst identified

Alpha Cognition is trading 5.03% down at $9.26, with no clearly identified company-specific catalyst for the August 26, 2026 decline. - Recent coverage...

πŸ”΄ Alpha Cognition is trading 5.23% down in pre-market β€” no company-specific catalyst identified

Alpha Cognition is trading 5.23% down at $9.24 after no new company-specific announcement was identified for August 24, 2026. - The latest material...

🟒 Alpha Cognition is trading 6% up today after B. Riley’s Buy rating and $21 target

Alpha Cognition is trading at $10.07, up 6.05%, with buying continuing after B. Riley initiated coverage on August 20 with a Buy rating and $21 target. - Q2...

🟒 Alpha Cognition is trading 10% up today after B. Riley initiated coverage at Buy

Alpha Cognition is trading 10.24% up at $9.80, likely supported by B. Riley initiating coverage at Buy with a $21 price target. - Continued enthusiasm follows...

🟒 Alpha Cognition is trading 10% up today amid possible continued investor interest after second-quarter results

Alpha Cognition is trading 9.73% up at $9.76, possibly reflecting continued investor interest after second-quarter results. - Results showed $6.0 million in...

🟒 Alpha Cognition rises 6.1% β€” Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results

With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...

Alpha Cognition Target Raised to $20 on Surging ZUNVEYL Revenue

Alpha Cognition Target Raised to $20 on Surging ZUNVEYL Revenue

H.C. Wainwright raised its price target for Alpha Cognition Inc. to $20 from $18. The firm maintained its Buy rating on the stock. The revision follows...

πŸ”΄ Alpha Cognition is trading 5% down today

Alpha Cognition is trading 5.09% down at $8.39, with no company-specific announcement identified to explain the August 17, 2026 decline. - The latest major...

🟒 Alpha Cognition is trading 7.18% up today after ZUNVEYL revenue rose approximately 71%

Alpha Cognition is trading 7.18% up now at $9.25 after reporting second-quarter results on August 13, 2026, with ZUNVEYL net product revenue rising...

🟒 Alpha Cognition is trading 11.7% up in pre-market after ZUNVEYL revenue rose approximately 71% sequentially

Alpha Cognition is trading 11.7% up now at $9.64 after reporting second-quarter results on August 13, 2026, as ZUNVEYL net product revenue rose approximately...

🟒 Alpha Cognition is trading 7.56% up in pre-market after ZUNVEYL net product revenue rose 71% sequentially

Alpha Cognition is trading 7.56% up in pre-market at $9.28 after reporting second-quarter results on August 13, 2026, including approximately 71% sequential...

Alpha Cognition's Alzheimer's Drug Sales Nearly Doubled in Q2 β€” But Can This Tiny Pharma Grow Fast Enough to Justify the Hype?

Alpha Cognition's Alzheimer's Drug Sales Nearly Doubled in Q2 β€” But Can This Tiny Pharma Grow Fast Enough to Justify the Hype?

Shares surged +11.8% to $9.65 after Alpha Cognition reported second-quarter revenue of $6.09 million, crushing the $4.32 million Wall Street consensus by 41%....

🟒 Alpha Cognition is trading 11.82% up in after-hours trading after a revenue beat

Alpha Cognition is trading at $9.65, up 11.82% in after-hours trading, with its revenue beat appearing to be the clearest company-specific catalyst. - The...

πŸ”΄ Alpha Cognition is trading 19.55% down in pre-market ahead of August 13 earnings release

Alpha Cognition is trading at $7.20, down 19.55% in pre-market as investors may be positioning ahead of its scheduled second-quarter 2026 earnings release and...

Alpha Cognition Inc Q2 2026 Earnings Preview: What Analysts Expect on August 13, 2026

Alpha Cognition (ACOG) is expected to report a Q2 2026 loss of -$0.39 per share on consensus revenue of $4.38 million, while currently trading near $9.13...

🟒 Alpha Cognition is trading 6% up today on momentum and broader biotech strength

Alpha Cognition is trading 6% up at $8.94, extending a strong move from recent sessions amid a broader rally in the biotech sector. β€’ The stock's advance...